Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beichen Biotech is a private biotechnology company founded in Shenzhen, China in 2021 that focuses on microbial technology R&D and industrial applications. The company appears to be building a platform around a proprietary microbial strain library, high-throughput screening, synthetic biology, and AI to discover and develop products for antimicrobial microecology and biomedicine. Publicly visible evidence suggests work spanning bacteriophages, phage lysins, probiotic and postbiotic products, and other microbiology-based products aimed at bacterial resistance and related health applications. Patent and literature traces indicate efforts in anti-infectives and functional microbial products rather than an advanced disclosed clinical drug pipeline. The company seems to be at an early, preclinical/platform stage with commercial activity in R&D services and related products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beichen Biotech.